Skip to content

Nurix Therapeutics, Inc. NRIX Compensation and benefits

Compensation and benefits at other companies

Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM

Other financials

Income statement

See full
Revenue$6.3M-66.1%
Operating income-$92.5M-47.1%
Net income-$87.2M-54.7%
EPS (diluted)-$0.79-17.9%

Balance sheet

See full
Cash & equivalents$72.2M-6.1%
Total debt$58.7M+120%
Total equity$480.9M0.0%
Total assets$636.1M+3.4%

Cash flow

See full
Operating cash flow-$71.9M-17.7%
CapEx$1.0M-70.0%
Free cash flow-$73.0M-13.0%

Valuation

See full
Market cap$1.95B+40.1%
Enterprise value$1.94B+45.1%
P/S27.2×+2.5×

Profitability

See full
Operating margin-439.3%+35.3pp
Net margin-411.4%+52.7pp
FCF margin-378.7%+24.1pp

Returns & leverage

See full
Return on equity-61.4%-2.5pp
Debt / equity0.1×+0.1×
Current ratio-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s compensation and benefits?
Nurix Therapeutics, Inc. (NRIX) reported compensation and benefits of $25.87M in Q4 2025.
How has Nurix Therapeutics, Inc.'s compensation and benefits changed year-over-year?
Nurix Therapeutics, Inc.'s compensation and benefits increased by 30.0% year-over-year, from $19.89M to $25.87M.
What is the long-term trend for Nurix Therapeutics, Inc.'s compensation and benefits?
Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s compensation and benefits has grown at a 17.8% compound annual growth rate (CAGR), from $13.16M to $21.54M.